Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Malignant Melanoma”

888 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 888 results

Early research (Phase 1)Study completedNCT00498979
What this trial is testing

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Who this might be right for
Stage IV Melanoma
Case Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Early research (Phase 1)Study completedNCT00219843
What this trial is testing

Intralesional PV-10 Chemoablation of Metastatic Melanoma

Who this might be right for
Melanoma
Provectus Pharmaceuticals 20
Post-approval studies (Phase 4)Ended earlyNCT01683188
What this trial is testing

HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Clinigen, Inc. 53
Large-scale testing (Phase 3)Study completedNCT02545075
What this trial is testing

A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine

Who this might be right for
Melanoma
Bristol-Myers Squibb 182
Testing effectiveness (Phase 2)Study completedNCT03278665
What this trial is testing

4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy

Who this might be right for
Malignant Melanoma
4SC AG 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03122522
What this trial is testing

Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

Who this might be right for
Metastatic Melanoma
Memorial Sloan Kettering Cancer Center 70
Early research (Phase 1)Study completedNCT00798629
What this trial is testing

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT02094872
What this trial is testing

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
Yale University 49
Testing effectiveness (Phase 2)UnknownNCT00538005
What this trial is testing

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 54
Testing effectiveness (Phase 2)Looking for participantsNCT05136196
What this trial is testing

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03617328
What this trial is testing

Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 33
Post-approval studies (Phase 4)Ended earlyNCT03673332
What this trial is testing

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

Who this might be right for
Advanced or Metastatic MelanomaAdvanced or Metastatic NSCLC
Institut Paoli-Calmettes 40
Testing effectiveness (Phase 2)Study completedNCT00082914
What this trial is testing

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00077532
What this trial is testing

Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 179
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728633
What this trial is testing

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Choroidal and Ciliary Body Melanoma AJCC V8
Thomas Jefferson University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Early research (Phase 1)Study completedNCT00317759
What this trial is testing

Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT02027935
What this trial is testing

CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT02941744
What this trial is testing

A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases

Who this might be right for
Stage IIIC Skin MelanomaStage IV Skin Melanoma
Universitair Ziekenhuis Brussel 56
Load More Results
150